Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients.
Minsung KimHanna KimSei Hyun AhnVafa TabatabaieSung Wook ChoiGuiyun SohnSae Byul LeeBeom Seok KoIl Yong ChungJisun KimJong Won LeeByung Ho SonHee Jeong KimPublished in: Breast cancer research and treatment (2020)
Premenopausal women who received adjuvant treatment which induced menopause showed significant bone loss which lasted for 5 years. Although no significant difference was observed between the O and T groups, tamoxifen treatment during chemotherapy or GnRH agonist treatment might prevent bone loss.